| 注册
首页|期刊导航|中国临床药理学杂志|丹参滴丸治疗糖尿病性冠心病的临床研究

丹参滴丸治疗糖尿病性冠心病的临床研究

胡思佳 彭应枝 余杨 周骏

中国临床药理学杂志2017,Vol.33Issue(6):486-489,4.
中国临床药理学杂志2017,Vol.33Issue(6):486-489,4.DOI:10.13699/j.cnki.1001-6821.2017.06.002

丹参滴丸治疗糖尿病性冠心病的临床研究

Clinical trial of Danshen dripping pill in the treatment of diabetic coronary heart disease

胡思佳 1彭应枝 2余杨 2周骏3

作者信息

  • 1. 浙江医院,三墩院区西药房,杭州310013
  • 2. 浙江医院,西药房,杭州310013
  • 3. 浙江医院,综合病房一,杭州310013
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of Danshen dripping pill combined with atorvastatin calcium tablets and metformin hydrochloride tablets in the treatmem of diabetic coronary heart disease.Methods Ninety-four patients with diabetic coronary heart diseases were randomly divided into control group (n =47 cases) and treatment group (n =47 cases).Control group was treated with atorvastatin calcium 20 mg qd + metformin hydrochloride 0.5 g tid.Treatment group was given Danshen dripping pill 270 mg per time,tid,on the basis of the control group.Two groups were treated for 3 months.The clinical efficacy,the levels of serum total cholesterol (TC),triglycerides (TG),low-density lipoprotein cholesterol (LDL-C),high density lipoprotein cholesterol(HDL-C),hemoglobinA1 c (HbA1 c),fasting blood glucose (FBG) and adverse drug reactions were compared between two groups,and the homeostasis model assessment insulin resistance (HOMA-IR) were calculated.Results After treatment,the total effective rates in treatment and control groups were 91.49% (43/47 cases) and 74.47% (35/47 cases) with significant difference(P < 0.05).After treatment,the main indexes in treatment and control groups were compared:TC were (3.05 ±0.21),(3.55 ±0.16)mmol · L-1;TG were(1.14 ± 0.16),(1.45 ± 0.14) mmol · L-1;LDL-C were(1.42 ±0.19),(1.74±0.19) mmol · L-1;HDL-C were(1.11 ±0.12),(1.40 ±0.15) mmol · L-1;HbA1c were (4.09 ± 0.50) %,(5.06 ± 0.71) %;FBG were (4.68 ± 0.61),(5.42 ± 0.93) mmol · L-1;HOMA-IR were (2.63 ±0.60),(3.66 ±0.59),the differences were statistically significant(P <0.05).The adverse drug reactions in two groups were based on increasing transaminase,flatulence,constipation,acute myocardial infarction,and so on.The incidences of treatment and control groups were 31.94% and 34.04% without significant difference (P > 0.05).Conclusion Danshen dripping pill combined with atorvastatin calcium tablets and mefformin hydrochloride tablets has a definitive clinical efficacy in the treatment of diabetic coronary heart disease,which can improve the levels of blood lipid and function of islet cells,decrease blood glucose,without increasing the incidence of adverse drug reactions.

关键词

丹参滴丸/阿托伐他汀钙片/二甲双胍片/糖尿病性冠心病/胰岛素抵抗

Key words

Danshen dripping pill/atorvastatin calcium tablet/metformin tablet/diabetic coronary heart disease/insulin resistance

分类

医药卫生

引用本文复制引用

胡思佳,彭应枝,余杨,周骏..丹参滴丸治疗糖尿病性冠心病的临床研究[J].中国临床药理学杂志,2017,33(6):486-489,4.

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文